Ampicillin prescribed by provider per standard of care for evaluation of early o
1 development in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is an actively recruiting Phase 1/2 interventional trial with no posted results; it aims to evaluate safety and pharmacokinetics of shortened ampicillin dosing in preterm neonates but has not yet reported outcomes.